Show pagesourceBacklinksCite current pageExport to PDFBack to top Share via Share via... Twitter LinkedIn Facebook Pinterest Telegram WhatsApp Yammer Reddit TeamsRecent ChangesSend via e-MailPrintPermalink × Prostate-specific antigen Development and clinical potential of (18)F-PSiMA for prostate cancer PET imagingClinical Outcomes of Metastasis-directed Therapy for Oligo-metastatic Prostate Cancer Diagnosed Using PSMA-PET/CT or Whole-body MRIPSMA radioligand uptake correlates with PSMA expression in high-grade glioma and brain metastasis: insights from a prospective PET-MRI guided multiregional biopsy studySurvival outcomes and clinical characteristics of brain metastases from prostate cancer: A single-center analysisSalvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trialA pH/STEAP Cascade-Responsive Nanomedicine with Self-Supplied Peroxide for Precise Chemodynamic TherapyExtra-axial small cell prostate carcinoma intracranial metastasis: illustrative caseThe effect of flavonoid and subclasses supplementation on prostate specific antigen, hormonal parameters and prostate cancer risk: a systematic review and meta-analysis of randomized controlled trials The Prostate-specific antigen test is a blood test to help detect prostate cancer prostate-specific_antigen.txt Last modified: 2024/06/07 02:48by 127.0.0.1